What is Suki?
Suki is at the forefront of developing advanced AI-driven voice solutions tailored for the healthcare industry. The company's core mission is to fundamentally reshape the healthcare technology infrastructure, making it seamless and supportive for medical professionals. By focusing on reducing the extensive administrative workload that physicians face, Suki aims to enhance efficiency and allow healthcare providers to concentrate more on patient care. Their innovative approach positions them as a key player in the digital transformation of healthcare.
How much funding has Suki raised?
Suki has raised a total of $161.6M across 5 funding rounds:
Series A
$15M
Series B
$20M
Debt
$1.6M
Series C
$55M
Series D
$70M
Series A (2018): $15M with participation from Social Capital, Venrock, and First Round Capital
Series B (2020): $20M led by Breyer Capital, Flare Capital Partners, Venrock, Epsilon Health, and First Round Capital
Debt (2021): $1.6M supported by PPP
Series C (2021): $55M featuring Philip Ventures, inHealth Ventures, March Capital, Breyer Capital, Flare Capital Partners, and Venrock
Series D (2024): $70M backed by Breyer Capital, Venrock, Hedosophia Services, and March Capital
Key Investors in Suki
Social Capital
Social Capital is a venture capital firm focused on solving the world's hardest problems by empowering entrepreneurs. They identify hard problems and assemble experts, IP, and experiments to deeply understand them before executing solutions through building, buying, or investing.
Venrock
Venrock is a historic venture capital firm founded in 1969, known for partnering with founders to build innovative, high-growth companies in technology and healthcare. They offer entrepreneurial support and strategic guidance.
First Round Capital
First Round Capital is a venture capital firm that invests in innovative startups across various sectors, focusing on supporting entrepreneurs and achieving significant results. They have a notable track record of successful IPOs and acquisitions.
What's next for Suki?
With the recent major enterprise-level funding, Suki is poised for accelerated growth and further development of its AI-powered voice solutions. This strategic investment will likely fuel expansion into new markets, enhance research and development efforts, and bolster the company's technological capabilities. The company's trajectory suggests a focus on scaling its operations to meet the growing demand for efficient healthcare technology. Future initiatives may include deeper integration into existing healthcare systems and the introduction of new AI-driven features to further streamline clinical workflows and improve physician productivity.
See full Suki company page
